Document is current
Any future updates will be listed below
-
Authors
Ramesh, Ganesh https://orcid.org/0009-0006-8232-6136
Sebestyen, Zsolt
Deshantri, Anil Kumar
Punt, Simone
Martinez Sanchez, Emma
Fernandez-Sojo, Jesus https://orcid.org/0000-0002-4016-0020
Querol, Sergi
Hudecek, Michael
Sanges, Carmen
Das, Ruud
Ballardini, Aiko
Eguizabal, Cristina
Geerts, Dirk
Ghavamzadeh, Ardeshir
Escamilla Gómez, Virginia https://orcid.org/0000-0002-0639-574X
Juan, Manel https://orcid.org/0000-0002-3064-1648
Larsen, Thomas Stauffer https://orcid.org/0000-0002-8418-6708
Lesný, Petr https://orcid.org/0000-0002-4198-5630
Lysák, Daniel https://orcid.org/0000-0001-9391-4247
Müller, Mirko https://orcid.org/0009-0001-7713-3798
Perpiñá, Unai
de Wilde, Sofieke https://orcid.org/0000-0003-2746-4537
Malard, Florent https://orcid.org/0000-0002-3474-0002
Hoogenboom, Jorinde
Mooyaart, Jarl
Ruggeri, Annalisa https://orcid.org/0000-0002-7261-2765
Straetemans, Trudy
Kuball, Jurgen https://orcid.org/0000-0002-3914-7806
-
Funding
Funding for this research was provided by:
NXTGEN Hightech Oncode Accelerator DARE-NL
- License Information
-
More Information
Article History
Received: 10 July 2025
Revised: 29 October 2025
Accepted: 19 November 2025
First Online: 17 December 2025
Competing interests
: JK is cofounder and shareholder of Gadeta Founders B.V., inventor on patents with γδTCR/ligand and genetic engineering related topics and has received research funding from Novartis, Miltenyi Biotech and Gadeta. For full disclosure, go to: . MJ has received research funding from Novartis. FM reports honoraria from BMS, Therakos, AstraZeneca, MSD, Sanofi, Priothera, and Novartis. AR reports honoraria from Gilead. CC reports honoraria from BMS, Kite/Gilead, Janssen, Jazz Pharmaceuticals, Miltenyi Biotec, Novartis. AS reports honoraria from Takeda, BMS/Celgene, MSD, Janssen, Amgen, Novartis, Gilead Kite, Sanofi, Roche, GenMab, Abbvie, Jazz Pharmaceuticals; Consultancy: Takeda, BMS/Celgene, Novartis, Janssen, Gilead, Sanofi, GenMab, Abbvie; Speaker’s Bureau: Takeda; Research Support: Takeda; Non-profit organizations: Presidency of the EBMT. ZS is an inventor with patents on γδ T-cells, their receptors and T-cell engineering strategies. All other authors have no relevant conflict of interest.
